Precision Engineering Solutions
Industrial & Process Water Equipment Portfolio
Explore our specialized membrane separation skids, fracturing fluid recycling setups, and degassing systems designed for aggressive industrial duties, biopharma compliance, and zero liquid discharge schemes.
Wholesale Deoxygenation Membrane Equipment Suppliers in China - Factory Solutions for Effective Water Treatment Suppliers, Manufacturers
Explore Specifications
CE Certification Osmosis-Assisted Reverse Osmosis Factory, Suppliers
Explore Specifications
OEM High-Ratio Water Reuse Equipment - Ultrafiltration & Reverse Osmosis by China Suppliers and Factory Suppliers, Supplier
Explore Specifications
China China Deoxygenation Membrane Equipment Factory - Suppliers of Physical Degassing Technology for Water Treatment Manufacturers, Manufacturer
Explore Specifications
Wholesale High-Salinity Wastewater Treatment System Factory in China: OARO Membrane Solutions from Reliable Suppliers Factory, Manufacturer
Explore Specifications
ODM China Suppliers Factory for Fracturing Flowback Water Reuse Treatment Equipment in Oil & Gas Operations Suppliers, Manufacturers
Explore Specifications
China China ODM Suppliers: Eco-Friendly Water Treatment Solutions from Leading Factory for Your Brand Factories, Manufacturers
Explore Specifications
Industry Intelligence & Procurement Architecture
Global Pharmaceutical Water Procurement Dynamics
Evaluating microbiological assurance, total cost of ownership (TCO), and cross-compendial compliance across the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Chinese Pharmacopoeia (ChP).
17+
Years Engineering Experience
38+
Patented Membrane Designs
<0.25
Endotoxin EU/mL (WFI Direct)
100%
Traceable Borescope Validation
Harmonized Quality Standards
Modern life-science manufacturing requires absolute compliance across multinational pharmacopeias. Water for Injection (WFI) and Purified Water (PW) plants must reliably balance physico-chemical attributes such as in-line conductivity (USP <645>) and Total Organic Carbon (USP <643>) under continuous, automated sanitary conditions.
- USP <645> Stage 1 conductivity monitoring (<1.3 µS/cm @ 25°C)
- TOC continuous detection below <500 ppb (clean loop limit <50 ppb)
- Microbiological bioburden <10 CFU/100 mL for PW, <10 CFU/100 mL for WFI
Total Cost of Ownership (TCO)
Capital expenditure (CAPEX) constitutes merely 22% to 30% of an industrial-scale high-purity water installation over a 10-year lifecycle. The operational expenditure (OPEX) profile is overwhelmingly governed by thermal energy consumption, CIP/SIP sanitization cycles, electrical pumping, and membrane replacement intervals.
- Hot water sanitization (80°C–85°C) eliminates hazardous biocide handling
- CEDI technology eliminates acid/caustic regenerant waste streams
- Variable frequency drives (VFDs) reduce annual loop circulation kW draw
GAMP 5 & 21 CFR Part 11 Control
Automated pharmaceutical skids must operate as validated black boxes with robust cyber-physical governance. Modern contract requirements stipulate tamper-evident audit trails, multi-tier cryptographic sign-offs, and continuous logging of critical process parameters (CPPs) to preserve data integrity.
- Industrial PLC architecture (Siemens S7-1500 or Rockwell ControlLogix)
- Immutable electronic records and batch-associated alarm event logging
- SCADA/MES seamless integration via standard OPC-UA protocol
Unit Operations & Clean Utilities
State-of-the-Art Technical Process Trains
From raw municipal intake to final cold membrane WFI distribution: engineered unit operations that prevent biofilm nucleation, mitigate endotoxins, and maximize hydraulic yield.
| Process Train Stage | Core Technology | Critical Removal Metric | Material of Construction | Sanitization Standard |
|---|---|---|---|---|
| Pretreatment | Dual Media Filtration + Simplex/Duplex Softener | Turbidity (SDI < 3), Total Hardness < 0.1 °dH | FRP / SS304 Skid with 316L Valves | Automated Brine/Backwash Cycling |
| Degasification | Hydrophobic Hollow Fiber Membrane Contactor | Dissolved Free CO₂ < 5 mg/L, O₂ reduction | Polypropylene Membranes / 316L Head | Periodic Clean-In-Place (CIP) |
| Desalination / RO | Double-Pass Thin Film Composite (TMC) RO | >99.2% Salt Rejection, Bacteria/Virus Barrier | SS316L High-Pressure Piping (EP) | 80°C Hot-Water Sanitizable Elements |
| Polishing (EDI) | Continuous Electro-Deionization (CEDI) | Resistivity > 15 MΩ·cm, TOC < 50 ppb | Sanitary CEDI Stacks / PEX/PVDF Internals | High-Temperature Thermal CIP (85°C) |
| Cold WFI Barrier | Ultrafiltration (6,000 Dalton MWCO) | Endotoxins < 0.03 EU/mL, Pyrogens | 316L Sanitary Housings (Ra < 0.38 µm) | Continuous Periodic Hot Water Flush |
| Thermal WFI | Multiple Effect Distillation (MED / VCD) | Sterile, Endotoxins < 0.01 EU/mL, Non-pyrogenic | AISI 316L Contact Parts (Ra < 0.4 µm) | Pure Steam (SIP) 121°C–134°C |
Membrane vs. Thermal WFI
Since the European Pharmacopoeia (Ph. Eur.) revision aligned with the USP permitting non-thermal generation of Water for Injection, pharmaceutical manufacturers have increasingly adopted Cold Membrane WFI systems. Combining double-pass reverse osmosis with continuous electro-deionization and ultrafiltration (RO+EDI+UF) slashes primary energy expenditures by up to 75% compared to multi-effect distillation columns.
Hydraulic Sanitary Distribution
Biofilm formation in stagnant zones remains the catastrophic point of failure in biopharmaceutical clean utilities. Our engineering guidelines adhere strictly to ASME BPE-2022 standards: incorporating autogenously welded AISI 316L (EN 1.4435) stainless steel, an internal surface finish of Ra ≤ 0.38 µm achieved via mechanical polishing and chemical electropolishing, and a strict 3D (dead-leg length to pipe diameter ratio) rule.
Continuous Thermal Sanitization
Eliminating sanitization chemical residues is paramount in modern formulation facilities. Our pharmaceutical distribution skid architectures incorporate secondary heat exchangers to maintain the entire storage and distribution loop at continuous self-sanitizing temperatures (75°C–80°C) or leverage fully automated, periodic superheated water cycles (minimum 85°C) calibrated with verifiable log-reduction F₀ value calculations.
R&D Horizons & Process Evolution
Technological Roadmap: 2026 to 2035
Strategic convergence of Industry 4.0 digital twin modeling, electrochemically-assisted concentration, and sustainable zero liquid discharge (ZLD) closed-loop engineering.
AI-Driven Digital Twins
Deploying dynamic virtual replicas of active water generation systems. Through continuous telemetry from differential pressure sensors, flow meters, and conductivity cells, machine learning algorithms forecast reverse osmosis membrane compaction and fouling velocity up to 90 days before hydraulic flux degradation manifests.
Rapid Micro-Testing (PAT)
Transitioning from traditional 5-day agar plate incubation culturing toward real-time Process Analytical Technology (PAT). Optical fluorescence cytometry and laser-induced bio-fluorescence allow direct, continuous, inline quantification of viable bacterial cell counts in circulating WFI lines.
Zero Emission Distillation
Electrification of pure steam generation using multi-stage vapor compression (VCD) units powered by high-efficiency scroll compressors. This completely decouples sterile pharmaceutical utility generation from industrial natural-gas fired boiler infrastructure, slashing plant scope 1 greenhouse gas footprints.
High-Salinity API ZLD
Integrating Osmosis-Assisted Reverse Osmosis (OARO) and Disc Tube Reverse Osmosis (DTRO) to handle toxic, high-salinity mother liquor effluents generated in active pharmaceutical ingredient (API) synthesis. Converting waste chemical streams into reusable pure condensates and crystallized solid salts.
Execution, Qualification & Compliance
Validation Lifecycle & Global Engineering Services
Turnkey commissioning models tailored to Contract Development and Manufacturing Organizations (CDMOs), biotechnology hubs, and global generic pharmaceutical corporations.
Design & Factory Acceptance (DQ / FAT)
Prior to modular containerization or skid dispatch from our Shanghai manufacturing headquarters, every water purification system undergoes rigorous qualification. Design Qualification (DQ) maps User Requirement Specifications (URS) directly to Functional Design Specifications (FDS). The Factory Acceptance Test (FAT) includes comprehensive wet-testing, hydraulic pressure holding tests, 100% orbital weld borescope video inspection, and calibration verification of all in-line analytical instruments.
Installation & Operational Testing (IQ / OQ)
Our site engineering deployment team provides on-ground mechanical and electrical interfacing. Installation Qualification (IQ) authenticates 3.1 material certificates for all contact components (AISI 316L, EPDM/PTFE gaskets compliant with FDA 21 CFR 177.2600), isometric slope verifications (minimum 1% fall to drain), and loop dead-leg audits. Operational Qualification (OQ) executes fault-state simulation, alarm escalation matrices, loop pump interlock failover verification, and automated SIP sequence challenges.
Performance Qualification (PQ Phase 1/2/3)
We provide complete documentary and consultative backing for end-user Performance Qualification (PQ). Phase 1 comprises daily testing of all generation and distribution sample ports over an intensive 2- to 4-week window to establish baselines. Phase 2 verifies process control under operational parameters over an additional month, and Phase 3 validates seasonal raw water fluctuations over a full year, demonstrating total bioburden and endotoxin containment.
Need Turnkey Pharmaceutical Clean Utility Engineering?
Connect directly with our senior process engineers to review your raw water chemistry, daily capacity demands, and targeted pharmacopeial monograph compliance.
Expert Technical Clarifications
Frequently Asked Engineering Questions
Direct technical answers addressing system design, validation protocols, regulatory updates, and operating parameters for sterile injectables and API production facilities.
What is the difference between USP Purified Water (PW) and Water for Injection (WFI)?
While both grades share identical physico-chemical specifications regarding Total Organic Carbon (TOC <500 ppb) and offline/online conductivity limits (Stage 1 <1.3 µS/cm at 25°C), their microbiological and endotoxin thresholds diverge significantly. USP/Ph. Eur. Purified Water allows up to 100 CFU/mL of microbial bioburden and does not mandate routine bacterial endotoxin testing. In contrast, WFI requires extremely stringent microbial control (<10 CFU/100 mL, a tenfold stricter standard) and enforces an explicit bacterial endotoxin threshold of <0.25 Endotoxin Units per milliliter (EU/mL), typically achieved via distillation or membrane ultrafiltration.
Is cold membrane-generated WFI legally permitted in the European Union?
Yes. Effective April 2017, the European Pharmacopoeia (Ph. Eur. monograph 0169) eliminated the exclusive mandate for distillation, aligning with the longstanding United States Pharmacopeia (USP) standard. Ph. Eur. allows "a purification process equivalent to distillation, such as reverse osmosis coupled with appropriate techniques (e.g., electro-deionization, ultrafiltration or nanofiltration)." However, European regulatory inspectors mandate extreme operational vigilance, including regular thermal sanitization capabilities, continuous TOC/conductivity monitoring, and robust integrity verification of the final ultrafiltration membranes.
Why is Continuous Electro-Deionization (CEDI) preferred over mixed-bed deionization?
Conventional chemically regenerated mixed-bed deionizers present major biopharmaceutical contamination risks and operational liabilities. They require batch chemical regenerations utilizing hazardous concentrated hydrochloric acid (HCl) and sodium hydroxide (NaOH), which generate corrosive effluent that requires neutralization. Furthermore, resin beds act as potential incubators for bacterial biofouling during downtime. CEDI continuously regenerates ion-exchange resins electrochemically via water dissociation under a DC electric field without chemical additions, maintains stable effluent resistivity >15 MΩ·cm, and withstands routine sanitization at temperatures up to 85°C.
What are the critical ASME BPE requirements for pharmaceutical distribution loops?
The American Society of Mechanical Engineers Bioprocessing Equipment (ASME BPE) standard dictates rigorous mechanical design rules: (1) Use of low-carbon austenitic stainless steel (AISI 316L or 1.4435) with sulfur content controlled between 0.005% and 0.017% to ensure weld uniformity; (2) Internal surface roughness of Ra ≤ 0.38 µm (15 µin) achieved by mechanical polishing followed by electropolishing; (3) Elimination of dead-legs by keeping branch lengths within 3 times the pipe diameter (L/D ≤ 3, with 1.5D preferred); and (4) Slope to drain requirements of at least 1:100 (1%) to prevent standing liquid.
How does continuous hot-loop circulation control microbial biofilms?
Biofilm formation occurs when planktonic bacteria adhere to pipe walls, exuding extracellular polymeric substances (EPS) that protect colonies from mild chemical disinfectants. By maintaining the purified water or WFI storage and distribution loop in a state of continuous turbulent flow (Reynolds number Re > 10,000) at an elevated temperature between 75°C and 80°C, the thermal energy constantly denatures bacterial cellular proteins and disrupts cell membrane integrity. This mechanical and thermal barrier permanently prevents microbiological attachment and proliferation without introducing chemical adulterants into product contact loops.
What validation documentation package is provided with an ODM water skid?
Every Tongjie pharmaceutical skid is delivered with a complete Good Automation Manufacturing Practice (GAMP 5) validation dossier. This comprehensive package includes: User Requirement Specification (URS) traceability matrix, Functional Design Specifications (FDS), piping and instrumentation diagrams (P&ID), 3.1 material test certificates for all wetted metallurgy, calibration certificates traceable to NIST standards for all sensors, orbital welding logs with 100% borescope video records, passivation reports, and pre-written IQ/OQ execution protocols with comprehensive test scripts ready for regulatory site filing.
Comprehensive Engineering Catalog
Extended Membrane & Industrial Water Lineup
Explore our full catalog of high-pressure membrane concentration, demineralized water skids, containerized sea water desalination plants, and specialized pharmaceutical WFI generators.
CE Certification High Salinity Brine Concentration System | OARO Technology from China Suppliers & Factory for ZLD Treatment Factories, Manufacturers
Explore Specifications
OEM High-Pressure DTRO&STRO Membrane Concentration System from China Suppliers and Factory for Wastewater Treatment Supplier, Manufacturer
Explore Specifications
China Water Reuse Equipment (Pretreatment + UF + RO Process) Factories, Supplier
Explore Specifications
ODM Pharmaceutical Purified Water & WFI System - Reliable China Suppliers and Factory Solutions for High-Quality Production Factories, Factory
Explore Specifications
Wholesale China Industrial Demineralized Water Equipment Factory - RO + EDI Suppliers for High-Quality Water Solutions Factory, Manufacturer
Explore Specifications
OEM China Suppliers: Containerized Seawater Desalination Plants from Factory for Instant Off-Grid Water Production Factories, Supplier
Explore Specifications
ODM High Salinity Brine Concentration System - China Factory Suppliers for Osmosis-Assisted Reverse Osmosis Solutions Factory, Manufacturer
Explore Specifications